Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma — Stella

Home/OESOPHAGO-GASTRIC CARCINOMA/

View on ClinicalTrials.gov

Recruiting

Back to OESOPHAGO-GASTRIC CARCINOMA trials

Trial locations(1 site)

United Kingdom

Imperial College NHS Healthcare Trust, London

Key details

Sponsor

Imperial College London

Enrollment target

~120 participants

Started

September 2024

Primary completion

August 2028

Age range

18 Years – 90 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.